Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017

Fig. 2

The global disease burden of AML in 195 countries or territories. a The incidence cases of 195 countries or territories in 2017, b the deaths of 195 countries or territories in 2017, and c the DALYs of 195 countries or territories in 2017. Note: AML, acute myeloid leukemia; DALY, disability-adjusted life year

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us